Safinamide Mesylate Patent Expiration
Safinamide Mesylate is Used for managing 'off' episodes in patients with Parkinson's disease who are already taking levodopa/carbidopa. It was first introduced by Mdd Us Operations Llc
Safinamide Mesylate Patents
Given below is the list of patents protecting Safinamide Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xadago | US8283380 | Methods for treatment of parkinson's disease | Mar 21, 2031 | Mdd Us |
| Xadago | US8076515 | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides | Dec 10, 2028 | Mdd Us |
| Xadago | US8278485 | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides | Jun 08, 2027 | Mdd Us |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Safinamide Mesylate's patents.
Latest Legal Activities on Safinamide Mesylate's Patents
Given below is the list recent legal activities going on the following patents of Safinamide Mesylate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Apr, 2024 | US8283380 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Apr, 2024 | US8278485 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Jun, 2023 | US8076515 |
| Patent Term Extension Certificate Critical
| 21 May, 2021 | US8283380 |
| Withdrawal of Application for PTE Critical
| 20 May, 2021 | US8076515 |
| Election in Response to Notice of Final Determination | 16 Mar, 2021 | US8283380 |
| Notice of Final Determination -Election Required | 09 Mar, 2021 | US8283380 |
| Notice of Final Determination -Election Required | 09 Mar, 2021 | US8076515 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 09 Apr, 2020 | US8283380 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Apr, 2020 | US8278485 |
Safinamide Mesylate's Family Patents
